Matsubara, Japan

Taisuke Hamamoto



Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 26(Granted Patents)


Location History:

  • Osaka, JP (2007)
  • Matsubara, JP (2009)

Company Filing History:


Years Active: 2007-2009

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Taisuke Hamamoto: Innovator in Pharmaceutical Chemistry

Introduction

Taisuke Hamamoto is a notable inventor based in Matsubara, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that focus on innovative compounds with therapeutic applications.

Latest Patents

Hamamoto's latest patents include an amide derivative that serves as a BCR-ABL tyrosine kinase inhibitor. This invention provides a compound represented by a specific general formula, which includes various functional groups that enhance its efficacy. Additionally, he has developed heterocyclic compound derivatives that act as PGI receptor agonists, contributing to the advancement of pharmaceutical compositions.

Career Highlights

Throughout his career, Taisuke Hamamoto has been associated with Nippon Shinyaku Company, Ltd., where he has played a crucial role in research and development. His work has focused on creating compounds that have the potential to treat various medical conditions, showcasing his dedication to improving healthcare through innovation.

Collaborations

Hamamoto has collaborated with esteemed colleagues such as Tetsuo Asaki and Keiichi Kuwano. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Taisuke Hamamoto's contributions to pharmaceutical chemistry through his innovative patents highlight his commitment to advancing medical science. His work continues to impact the industry positively, paving the way for future developments in drug discovery and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…